Orthogonal inactivation of influenza and the creation of detergent resistant viral aggregates: Towards a novel vaccine strategy

Virology Journal

Volumn 9, Issue , 2012, Pages

  Belanger, Julie M ^a,c   Raviv, Yossef ^b   Viard, Mathias ^b   Baxa, Ulrich ^b   Blumenthal, Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c KING'S COLLEGE   (United States)

Author keywords

Detergent; Detergent resistance; Hemagglutinin; HIV 1; Human immunodeficiency virus; Inactivation; Influenza virus; Orthogonal; Triton; Vaccine

Indexed keywords

EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; TRITON X 100; ANTIVIRUS AGENT; DETERGENT;

ARTICLE; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; DRUG EFFICACY; DRUG SAFETY; IMMUNOGOLD LABELING; IMMUNOPRECIPITATION; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; ORTHOLOGY; ULTRACENTRIFUGATION; ULTRAVIOLET A RADIATION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS STRAIN; DRUG EFFECT; HUMAN; IMMUNOLOGY; ORTHOMYXOVIRUS; PATHOGENICITY; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; VIRUS INACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; ORTHOMYXOVIRIDAE;

ANTIVIRAL AGENTS; DETERGENTS; HUMANS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE; ULTRAVIOLET RAYS; VIRUS INACTIVATION;

EID: 84858739578     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-72     Document Type: Article

References (20)

1. Conference reports: workshop on HIV inactivated vaccines. Schultz AM, Koff CW, Lawrence DN, Vaccine 1990 8 516 517 (Pubitemid 20332865)
2. Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs. Geeraedts F, Bungener L, Pool J, ter Veer W, Wilschut J, Huckriede A, Influenza Other Respi Viruses 2008 2 41 51 10.1111/j.1750-2659.2008.00038.x 19453471
3. The challenges of elliciting neutralizing antibodies to HIV-1 and to influenza virus. KarlssonHedestam GB, Fouchier RAM, Phogat S, Burton DR, Sodroski J, Wyatt RT, Nat Rev Microbiol 2008 6 143 155 10.1038/nrmicro1819 18197170
4. 5-[125I] Iodonaphthylazide, a reagent to determine the penetration of proteins into the lipid bilayer of biological membranes. Bercovici T, Gitler C, Biochemistry 1978 17 1484 1489 10.1021/bi00601a020 148291 (Pubitemid 8330385)
5. Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent. Warfield KL, Swenson DL, Olinger GG, Kalina WV, Viard M, Aitichou M, Chi X, Ibrahim S, Blumenthal R, Raviv Y, et al. J Infect Dis 2007 196 276 S283 10.1086/520605 17940961 (Pubitemid 351417272)
6. Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity. Raviv Y, Blumenthal R, Tompkins SM, Humberd J, Hogan RJ, Viard M, J Virol 2008 82 4612 4619 10.1128/JVI.02233-07 18305038 (Pubitemid 351563697)
7. Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope. Raviv Y, Viard M, Bess JW Jr, Chertova E, Blumenthal R, J Virol 2005 79 12394 12400 10.1128/JVI.79.19.12394-12400.2005 16160166 (Pubitemid 41346101)
8. Characterization of the effects of aryl-azido compounds and UVA irradiation on the viral proteins and infectivity of human immunodeficiency virus type 1. Belanger JM, Raviv Y, Viard M, de la Cruz JM, Nagashima K, Blumenthal R, PhotochemPhotobiol 2010 86 1099 1108
9. Complete inactivation of venezuelan equine encephalitis virus by 1,5-iodonaphthylazide. Sharma A, Raviv Y, Puri A, Viard M, Blumenthal R, Maheshwari RK, BiochemBiophys Res Commun 2007 358 392 398 10.1016/j.bbrc.2007. 04.115 (Pubitemid 46755721)
10. Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1). Belanger JM, Raviv Y, Viard M, de la Cruz JM, Nagashima K, Blumenthal R, Virology 2011 417 1 221 228 21726886
11. HPLC of Membrane Proteins. Welling GW, van der Zee R, Welling-Wester S, Chromatographic Science Series New York: Marcel Dekker, Inc, Gooding KM, Regnier FE, secondth 2002 Volume 87 500 530
12. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. Yu J, Fischman DA, Steck TL, J Supramol Structure 1973 1 233 248 10.1002/jss.400010308
13. Differential solubilization of proteins, phospholipids and cholesterol of erythrocyte membranes by detergents. Kirkpatrick FH, Gordesky SE, Marinetti GV, BiochimBiophysActa 1974 345 154 161
14. Lipid raft-dependent targeting of the influenza A virus nucleoprotein to the apical plasma membrane. Carrasco M, Amorium MJ, Digard P, Traffic 2004 5 979 992 10.1111/j.1600-0854.2004.00237.x 15522099 (Pubitemid 39534489)
15. Induction of influenza A virus cross-reactive cytotoxic t cells by a nuceloprotein/haemagglutinin preparation. Wraith DC, Askonas BA, J Gen Virol 1985 66 1327 1331 10.1099/0022-1317-66-6-1327 3874261 (Pubitemid 15027200)
16. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. Jonges M, Liu WM, van der Vries E, Jacobi R, Pronk I, Boog C, Koopmans M, Meijer A, Soethout E, J ClinMicrobiol 2010 48 928 940
17. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. Lutz A, Dyall J, Olivo PD, Pekosz A, J Virol Methods 2005 126 13 20 10.1016/j.jviromet.2005.01.016 15847914 (Pubitemid 40558738)
18. Product information sheet for NR-3148. BEI Resources
19. UNIT 15G.1: Influenza: Propagation, Quantification, and Storage. Szretter KJ, Balish AL, Katz JM, CurrProtMicrobiol 2006 15G.11.11 15G.11.22
20. New low-viscosity overlay medium for viral plaque assays. Matrosovich M, Matrosovich T, Garten W, Klenk H-D, Virology Journal 2006 3